Taiwan Bio Therapeutics Co., Ltd (TPEX:6892)
Taiwan · Delayed Price · Currency is TWD 25.80
-1.00 (-3.73%)
Oct 30, 2026, 1:48 PM CST
Taiwan Bio Therapeutics Market Cap
Taiwan Bio Therapeutics has a market cap or net worth of 2.19 billion as of October 30, 2026. It is the 27,887th most valuable company in the world and the 1,578th biggest in Taiwan. Its market cap has decreased by 13.81% in one year.
Market Cap
2.19B
Enterprise Value
n/a
Revenue
n/a
Global Rank
Country Rank
#1,578 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since May 13, 2022, Taiwan Bio Therapeutics's market cap has increased from 1.93B to 2.19B, an increase of 13.47%. That is a compound annual growth rate of 2.87%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 2.19B | -9.12% |
| Dec 31, 2025 | 2.41B | -31.88% |
| Dec 31, 2024 | 3.54B | 103.07% |
| Dec 29, 2023 | 1.74B | 7.86% |
| Dec 30, 2022 | 1.62B | -16.32% |
| May 13, 2022 | 1.93B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Senhwa Biosciences | 2.77B |
| Great Novel Therapeutics Biotech & Medicals | 2.73B |
| Chunghwa Chemical Synthesis & Biotech | 2.48B |
| GlycoNex Incorporation | 2.40B |
| Syngen Biotech | 2.28B |
| HeXun Biosciences | 2.26B |
| 3D Global Biotech | 2.15B |
| Gwo Xi Stem Cell Applied Technology Co. , | 2.03B |